Lipids, Lipoproteins, and Cardiovascular Risk Factors

Citations 221-230 of 519 total displayed.

Past content (since Jan 1997):

Letters to the Editor
3-Deazaadenosine, a Stabilizer of Whole-Blood Homocysteine Content, Does Not Interfere with the Single-Enzyme Homocysteine Assay while Totally Inhibiting the Enzyme Conversion Homocysteine Immunoassay

Qinghong Han, Xinghua Sun, Mingxu Xu, Nan Zhang, Li Tang, Yuying Tan, and Robert M. Hoffman
Clin. Chem. 2004; 50: 1703-1704. [Extract] [Full text] [PDF]  

Editorials
Homocysteine and Folate in Pregnancy

Per Magne Ueland and Stein Emil Vollset
Clin. Chem. 2004; 50: 1293-1295. [Extract] [Full text] [PDF]  

Lipids, Lipoproteins, and Cardiovascular Risk Factors
Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians’ Health Study

Nader Rifai, Jing Ma, Frank M. Sacks, Paul M. Ridker, Wendy Jade L. Hernandez, Meir J. Stampfer, and Santica M. Marcovina
Clin. Chem. 2004; 50: 1364-1371. [Abstract] [Full text] [PDF]  

Nutrition
Maternal Homocysteine before Conception and throughout Pregnancy Predicts Fetal Homocysteine and Birth Weight

Michelle M. Murphy, John M. Scott, Victoria Arija, Anne M. Molloy, and Joan D. Fernandez-Ballart
Clin. Chem. 2004; 50: 1406-1412. [Abstract] [Full text] [PDF]  

Technical Briefs
Biological Variation of Plasma F₂-Isoprostane-III and Arachidonic Acid in Healthy Individuals

Xiongwen Yu, Chung S. Ho, and Christopher W.K. Lam
Clin. Chem. 2004; 50: 1428-1430. [Extract] [Full text] [PDF]  

Letters to the Editor
Urinary Methylmalonic Acid Test May Have Greater Value than the Total Homocysteine Assay for Screening Elderly Individuals for Cobalamin Deficiency

Eric J. Norman
Clin. Chem. 2004; 50: 1482-1483. [Extract] [Full text] [PDF]  

Editorials
Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications

Milada Dobiásová
Clin. Chem. 2004; 50: 1113-1115. [Extract] [Full text] [PDF]  

Lipids, Lipoproteins, and Cardiovascular Risk Factors
Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes

Meng H. Tan, Don Johns, and N. Bradly Glazer
Clin. Chem. 2004; 50: 1184-1188. [Abstract] [Full text] [PDF]  

Lipids, Lipoproteins, and Cardiovascular Risk Factors
Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study

David S. Freedman, James D. Otvos, Elias J. Jeyarajah, Irina Shalaurova, L. Adrienne Cupples, Helen Parise, Ralph B. D’Agostino, Peter W.F. Wilson, and Ernst J. Schaefer
Clin. Chem. 2004; 50: 1189-1200. [Abstract] [Full text] [PDF]  

Lipids, Lipoproteins, and Cardiovascular Risk Factors
Comparison of Ultracentrifugation and Nuclear Magnetic Resonance Spectroscopy in the Quantification of Triglyceride-Rich Lipoproteins after an Oral Fat Load

Michael Y. Tsai, Angeliki Georgopoulos, James D. Otvos, Jose M. Ordovas, Naomi Q. Hanson, James M. Peacock, and Donna K. Arnett
Clin. Chem. 2004; 50: 1201-1204. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52